20% goes into R&D, 30% goes into Marketing, 25% goes operating costs, 25% is profit. Since a lot of Pharma research is done at universities and is funded by th

20% goes into R&D, 30% goes into Marketing, 25% goes operating costs, 25% is profit. Since a lot of Pharma research is done at universities and is funded by the public, this holds true especially for insulin, maybe by cutting the costs of meds the companies optimise their system more. Less marketing, no Pharma people bribing doctors to use their meds etc. I bet if you cut those unnecessary jobs and expenses before touching R&D or Profit a lot can be done.